Efficacy of auricular plaster therapy for sleep disorders in preschool children with autism spectrum disorders: Study protocol for a randomized controlled trial

Duoxi Duan, Lin He, Hong Chen, Lei Ying, Wei Wu, Tao LiFrontiers in Neurology 2022 · DOI

This paper presents a detailed study protocol for a randomized controlled trial (RCT) investigating whether a non-invasive Traditional Chinese Medicine (TCM) technique—auricular plaster therapy (APT)—can effectively treat sleep disorders in preschool children with Autism Spectrum Disorder (ASD).

TL;DR

Researchers have designed a randomized controlled trial to evaluate auricular plaster therapy (APT) as a non-pharmacological treatment for sleep disorders in children with autism. By applying cowherb seeds to specific ear acupoints, the study aims to provide a safe, parent-administered alternative to current treatments like melatonin.

What Problem Does This Paper Address?

Sleep disorders affect over 44% of children with ASD, manifesting as difficulty falling asleep, frequent night-waking, and poor sleep quality. These issues often exacerbate the core symptoms of autism, such as irritability and repetitive behaviors, creating a "vicious cycle" for both children and their caregivers.

Currently, clinical guidelines are thin. Behavioral strategies are the first line of defense but require immense time and patience. Pharmacological options, primarily melatonin, are common but carry concerns regarding long-term safety, potential side effects (like dizziness or bedwetting), and inconsistent efficacy in the pediatric ASD population. There is a clear need for a treatment that is effective, safe, and easy for parents to implement at home.

Methods

The study is a single-center, patient-assessor blind, randomized controlled trial.

  • Participants: 44 preschool children (ages 2–6) diagnosed with both ASD and sleep disorders.
  • The Intervention (APT): The treatment group receives auricular plasters—small adhesive tapes containing a hard cowherb seed—applied to six specific acupoints on the ear (Heart, Jiaogan, Shenmen, Subcortex, Kidney, and Spleen). Parents are instructed to press these points three times a day to stimulate the points.
  • The Control (Sham APT): To account for the placebo effect, the control group receives identical-looking plasters but without the cowherb seeds, and parents are not instructed to press them.
  • Duration: The intervention lasts 30 days, with a follow-up period extending to 120 days post-randomization.
  • Blinding: While the acupuncturist cannot be blinded, the participants (children/parents) and the outcome assessors remain unaware of the group assignments.

Datasets

As this is a study protocol, the "dataset" consists of the standardized clinical tools used for evaluation:

  • CSHQ (Children’s Sleep Habits Questionnaire): The primary outcome measure, used to assess various sleep domains via parent reports.
  • ABC (Autism Behavior Checklist): A secondary measure to see if improved sleep correlates with improved daytime behavior.
  • PSG (Polysomnography): Considered the "gold standard" of sleep research, PSG provides objective data on sleep architecture, including total sleep time, sleep latency, and REM cycles.
  • Safety Data: Systematic tracking of adverse events (AEs) like skin allergies or pain.

Key Insights and Ideas

  • TCM Physiological Model: The protocol selects acupoints based on TCM theory, which attributes ASD-related sleep issues to deficiencies in the Spleen and Kidney and imbalances in the "Heart spirit." This provides a structured physiological hypothesis for why specific points are targeted.
  • Parent-Mediated Therapy: Unlike traditional acupuncture, APT allows parents to perform the "stimulation" phase of the therapy. This increases the dosage of the treatment without requiring daily clinic visits, potentially improving compliance in a population that often struggles with new environments.
  • Objective vs. Subjective Data: By combining the CSHQ (subjective parent report) with PSG (objective physiological data), the researchers aim to provide a robust validation of the therapy that moves beyond anecdotal evidence.

Key Results

Quantitative results are not yet available as this is a protocol. However, the researchers hypothesize that the APT group will show significant improvements in CSHQ scores and more stable sleep architecture (increased total sleep time and decreased latency) compared to the sham group. They also expect these benefits to persist through the 120-day follow-up.

Limitations and Future Work

The authors acknowledge several hurdles:

  • Sample Size: With only 44 participants, the study may lack the power to detect subtle effects or sub-group differences.
  • The "First-Night Effect": PSG can be highly stressful for children with ASD. The protocol only includes one night of PSG monitoring, which might be skewed by the child's discomfort with the equipment and environment.
  • Blinding Integrity: Despite using sham plasters, the physical sensation (or lack thereof) of the seed might lead some parents to guess their group assignment, potentially introducing bias.

If this pilot study proves successful, the next logical step would be a larger, multi-center trial to confirm the findings and explore the underlying neurobiological mechanisms of how auricular stimulation affects sleep-regulating neurotransmitters.

Summary updated

Abstract

Background Children with autism spectrum disorders (ASDs) suffer from sleep disorders to a considerable degree; however, there is no safe and effective treatment available in clinical practice. The objective of the trial is to assess the clinical effectiveness of auricular plaster therapy (APT) in treating sleep disorders in children with ASD. Method This is a single-center, patient-assessor blind, randomized controlled trial. A total of 44 preschool children with sleep disorders with ASD will be included in this study. Eligible participants will be randomly assigned to either the auricular plaster group or the sham auricular plaster group in a 1:1 ratio. Participants in the different groups will receive APT or sham APT, respectively, for a total of 30 sessions over 30 days. The primary outcome includes the Children's Sleep Habits Questionnaire (CSHQ), while secondary outcomes include the Autism Behavior Checklist (ABC) and polysomnography (PSG) for total sleep time, sleep latency, awakening duration, and sleep structures. The CSHQ and ABC will be assessed at baseline, 10, 20, 30, 60, 90, and 120 days after randomization, whereas PSG will be assessed at baseline and 30 days after randomization. The follow-up period will be scheduled to be 60, 90, and 120 days after randomization. Discussion The results of this study may provide evidence of the efficacy of APT, as well as offer new alternatives for the treatment of sleep disorders in children with ASD. Trial registration CHiCTR.org.cn (ChiCTR2100048257). Registered on July 5, 2021.
BibTeX
@inproceedings{duan2022efficacy,
  author = {Duoxi Duan and Lin He and Hong Chen and Lei Ying and Wei Wu and Tao Li},
  title = {{Efficacy of auricular plaster therapy for sleep disorders in preschool children with autism spectrum disorders: Study protocol for a randomized controlled trial}},
  booktitle = {Frontiers in Neurology},
  year = {2022},
  doi = {10.3389/fneur.2022.973609},
}
Figure